RU2023125855A - NEOANTIGENS AND THEIR APPLICATION - Google Patents

NEOANTIGENS AND THEIR APPLICATION Download PDF

Info

Publication number
RU2023125855A
RU2023125855A RU2023125855A RU2023125855A RU2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A RU 2023125855 A RU2023125855 A RU 2023125855A
Authority
RU
Russia
Prior art keywords
polypeptide
neoantigens
application
gavgvgksal
gavgvgksa
Prior art date
Application number
RU2023125855A
Other languages
Russian (ru)
Inventor
Викрам ДЖУНЕДЖА
Original Assignee
БАЙОНТЕК ЮЭс ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by БАЙОНТЕК ЮЭс ИНК. filed Critical БАЙОНТЕК ЮЭс ИНК.
Publication of RU2023125855A publication Critical patent/RU2023125855A/en

Links

Claims (6)

Композиция, содержащая:Composition containing: (а) по меньшей мере один полипептид или его фармацевтически приемлемую соль, содержащий две или более мутантных RAS пептидных последовательностей, выбранных из группы, состоящей из;(a) at least one polypeptide or a pharmaceutically acceptable salt thereof comprising two or more mutant RAS peptide sequences selected from the group consisting of; (i) KLVVVGADGV, KLVVVGACGV, KLVVVGAVGV, LVVVGADGV, LVVVGACGV, LVVVGAVGV;(i) KLVVVGADGV, KLVVVGACGV, KLVVVGAVGV, LVVVGADGV, LVVVGACGV, LVVVGAVGV; (ii) GADGVGKSAL, GACGVGKSAL, GAVGVGKSAL, GADGVGKSA, GACGVGKSA, GAVGVGKSA; и/или(ii) GADGVGKSAL, GACGVGKSAL, GAVGVGKSAL, GADGVGKSA, GACGVGKSA, GAVGVGKSA; and/or (iii) VVGADGVGK, VVGACGVGK, VVGAVGVGK, VVVGADGVGK, VVVGACGVGK, VVVGAVGVGK; или(iii) VVGADGVGK, VVGACGVGK, VVGAVGVGK, VVVGADGVGK, VVVGACGVGK, VVVGAVGVGK; or (b) по меньшей мере один полинуклеотид, кодирующий по меньшей мере один полипептид.(b) at least one polynucleotide encoding at least one polypeptide.
RU2023125855A 2018-06-19 2019-06-19 NEOANTIGENS AND THEIR APPLICATION RU2023125855A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62/687,188 2018-06-19
US62/800,735 2019-02-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2021100733A Division RU2805196C2 (en) 2018-06-19 2019-06-19 Neoantigens and their application

Publications (1)

Publication Number Publication Date
RU2023125855A true RU2023125855A (en) 2023-10-16

Family

ID=

Similar Documents

Publication Publication Date Title
RU2018122823A (en) PROTEIN MUTANTS F RSV
EA201990885A1 (en) COMPOSITIONS CONTAINING SHORT PEPTIDES OBTAINED FROM PEDF AND THEIR APPLICATION
IL232501A (en) Proteinase-resistant analogs of peptide or polypeptide and uses thereof
BR112017007816A2 (en) pharmaceutical compositions comprising peptide variants and methods of using them
ES2528133T3 (en) Peptides and compositions for prevention of cell adhesion, and methods for using them
NZ628987A (en) Extended recombinant polypeptides and compositions comprising same
MX2017016105A (en) Adenovirus polynucleotides and polypeptides.
WO2019148026A8 (en) Il-22 fc fusion proteins and methods of use
CL2017003097A1 (en) Compositions and methods for the treatment of celiac disease
WO2019084343A8 (en) Peptide compositions and methods of use thereof
EA202192925A1 (en) SOLID FORMS OF THE GLYT1 INHIBITOR
WO2020008377A3 (en) Ionic self-assembling peptides
EA202190240A1 (en) RECOMBINANT PROTEIN OPTIONS
EP3946410A4 (en) Therapeutic interferon alpha 1 proteins
BR112018013246A2 (en) peptide label and labeled protein including the same
WO2018189661A3 (en) Methods and compounds for treating diabetes
RU2023125855A (en) NEOANTIGENS AND THEIR APPLICATION
MX2021004879A (en) Klk5 inhibitory peptide.
EA202090143A1 (en) PHARMACEUTALLY ACCEPTABLE SALTS OF POLYPEPTIDES AND THEIR APPLICATION
EA201992587A1 (en) PEPTIDES AND THEIR APPLICATION AS ANTIVIRAL AGENTS
EA202092963A1 (en) NEW PROTEIN WITH ANTI-INFLAMMATORY PROPERTIES
JP2019218304A5 (en)
WO2019237075A8 (en) Epha2 agonists and uses thereof
EA202190531A1 (en) COLLECTIONS OF PEPTIDES, PEPTIDE AGENTS AND METHODS OF THEIR APPLICATION
RU2022114441A (en) MODIFIED L-ASPARAGINASE